Cargando...
Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design
Although docetaxel was approved for the treatment of metastatic castration-resistant prostate cancer in 2004, additional therapies are still required. Prostate cancer is often slow-growing and expresses many tumor-associated antigens, making it a feasible target for immunotherapy. Several therapeuti...
Gardado en:
| Publicado en: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628898/ https://ncbi.nlm.nih.gov/pubmed/19857185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712590903321421 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|